HCW Biologics Files S-1/A Amendment
Ticker: HCWB · Form: S-1/A · Filed: May 13, 2025 · CIK: 1828673
Sentiment: neutral
Topics: sec-filing, registration, amendment
TL;DR
HCW Biologics filed an S-1/A amendment, signaling progress on its securities registration.
AI Summary
HCW Biologics Inc. filed an S-1/A on May 13, 2025, as Pre-Effective Amendment No. 1 to its Form S-1 Registration Statement. The filing, with registration number 333-287136, pertains to the company's securities under the Securities Act of 1933. HCW Biologics Inc. is incorporated in Delaware and its principal executive offices are located at 2929 N Commerce Parkway, Miramar, FL 33025.
Why It Matters
This filing indicates HCW Biologics Inc. is moving forward with its registration process for securities, which could lead to a public offering or other significant corporate actions.
Risk Assessment
Risk Level: medium — S-1/A filings are typically associated with upcoming public offerings, which inherently carry market and execution risks.
Key Numbers
- 333-287136 — SEC Registration Number (Identifies this specific securities registration filing.)
Key Players & Entities
- HCW Biologics Inc. (company) — Registrant
- May 13, 2025 (date) — Filing Date
- 333-287136 (registration_number) — SEC Registration Number
- Delaware (jurisdiction) — State of Incorporation
- 2929 N Commerce Parkway, Miramar, FL 33025 (address) — Principal Executive Offices
- Hing C. Wong, Ph.D. (person) — Chief Executive Officer
- James Groth (person) — Agent for Service (Clark Hill PLC)
- Randolf Katz (person) — Legal Counsel (Clark Hill PLC)
- Barry I. Grossman, Esq. (person) — Legal Counsel
- Matthew Berns (person) — Legal Counsel
FAQ
What is the purpose of this S-1/A filing?
This filing is a Pre-Effective Amendment No. 1 to the Form S-1 Registration Statement, indicating updates or revisions to the initial registration filing for HCW Biologics Inc.'s securities.
When was this amendment filed?
The filing was made on May 13, 2025.
Where is HCW Biologics Inc. headquartered?
The company's principal executive offices are located at 2929 N Commerce Parkway, Miramar, FL 33025.
Who is the Chief Executive Officer of HCW Biologics Inc.?
Hing C. Wong, Ph.D. is the Chief Executive Officer.
What is the SEC file number associated with this registration?
The SEC file number is 333-287136.
Filing Details
This Form S-1/A (Form S-1/A) was filed with the SEC on May 13, 2025 by Hing C. Wong, Ph.D. regarding HCW Biologics Inc. (HCWB).